These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 77866)

  • 1. The clinical and immunologic specificity of immunotherapy.
    Norman PS; Lichtenstein LM
    J Allergy Clin Immunol; 1978 Jun; 61(6):370-7. PubMed ID: 77866
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy.
    Arvidsson MB; Löwhagen O; Rak S
    J Allergy Clin Immunol; 2002 May; 109(5):777-83. PubMed ID: 11994699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apropos of sublingual specific immunotherapy].
    Sabbah A
    Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sublingual vs subcutaneous immunotherapy].
    Olivé Pérez A
    Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale for immunotherapy in respiratory allergies.
    Norman PS
    Trans Am Clin Climatol Assoc; 1978; 89():119-29. PubMed ID: 309208
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy for mountain cedar pollinosis. A double-blind controlled study.
    Pence HL; Mitchell DQ; Greely RL; Updegraff BR; Selfridge HA
    J Allergy Clin Immunol; 1976 Jul; 58(1 PT 1):39-50. PubMed ID: 780406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
    Ariano R; Panzani RC; Augeri G
    Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosis.
    Taudorf E; Laursen L; Lanner A; Björkstén B; Dreborg S; Weeke B
    J Allergy Clin Immunol; 1989 Mar; 83(3):589-94. PubMed ID: 2647818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rush immunotherapy with a standardized Bermuda grass pollen extract.
    Armentia-Medina A; Blanco-Quiros A; Martin-Santos JM; Alvarez-Cuesta E; Moneo-Goiri I; Carreira P; Losada-Cosmes E
    Ann Allergy; 1989 Aug; 63(2):127-35. PubMed ID: 2669567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
    Ariano R; Panzani RC; Augeri G
    J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
    Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
    Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immunotherapy on eosinophil activation in pollen sensitive children.
    Pronk-Admiraal CJ; Schilte PP; Bartels PC
    Clin Lab; 2001; 47(5-6):231-8. PubMed ID: 11405601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study.
    Kuna P; Alam R; Kuzminska B; Rozniecki J
    J Allergy Clin Immunol; 1989 Apr; 83(4):816-24. PubMed ID: 2468702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL; Sobotka AK; Valentine MD
    J Allergy Clin Immunol; 1980 Apr; 65(4):288-97. PubMed ID: 6987291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever.
    Lichtenstein LM; Norman PS; Winkenwerder WL
    Am J Med; 1968 Apr; 44(4):514-24. PubMed ID: 4171086
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peroral desensitization of inhalation allergies in childhood: treatment results].
    Laetsch C; Wüthrich B
    Schweiz Med Wochenschr; 1973 Mar; 103(9):342-7. PubMed ID: 4144381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specific desensitizing therapy in the treatment of respiratory allergic diseases].
    Noferi A; Ferrante E; Testa A
    Folia Allergol (Roma); 1966; 13(4):280-9. PubMed ID: 5990235
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL; Sobotka AK; Valentine MD
    J Allergy Clin Immunol; 1980 Dec; 66(6):500-13. PubMed ID: 6159384
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.